Company
ADXN · CIK 0001574232
Acquisition (code A) of 16,413,787 shares at $0 per share.
Reporting Person Dyer Timothy Mark · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code A
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001104659-26-105481 · filed 2026-09-04 · View filing →
Acquisition (code A) of 1,365,532 shares at $0 per share.
Reporting Person Hill Raymond George · Transaction Code A
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001104659-26-105484 · filed 2026-09-04 · View filing →
Acquisition (code A) of 2,507,487 shares at $0 per share.
Reporting Person Lawton Vincent Michael · Transaction Code A
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001104659-26-105489 · filed 2026-09-04 · View filing →
Acquisition (code A) of 219,561 shares at $0 per share.
Reporting Person Manke Isaac · Transaction Code A
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001104659-26-105491 · filed 2026-09-04 · View filing →
Acquisition (code A) of 392,837 shares at $0 per share.
Reporting Person Mills Roger · Officer Title CHIEF MEDICAL OFFICER · Transaction Code A
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001104659-26-105496 · filed 2026-09-04 · View filing →
Acquisition (code A) of 219,561 shares at $0 per share.
Reporting Person Nunn Jason Raleigh · Transaction Code A
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001104659-26-105501 · filed 2026-09-04 · View filing →
Acquisition (code A) of 306,765 shares at $0 per share.
Reporting Person Kalinichev Mikhail · Officer Title HEAD OF TRANSLATIONAL SCIENCE · Transaction Code A
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001104659-26-105506 · filed 2026-09-04 · View filing →